This is Part 2 of the breakdown of Yale Medicine's article on the new subvariant Eres as well as information on the new vaccine. The new vaccine program is set to be unveiled next week with a request for all Americans to get this new version. Data, however, shows us that not only is this new version targeting an outdated strain, but the new illness is considered mild anyway. A few subsequent episodes to come on this topic, stay tuned!